XML 63 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Equity Incentive Plans (Tables)
12 Months Ended
Dec. 31, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Restricted Stock Awards Activity

The following table summarizes the RSA activity of the Company’s plans as of and for the years ended December 31, 2021 and 2020:

 

 

 

Number of
shares

 

 

Weighted Average
Grant-Date
Fair Value

 

Unvested restricted common stock outstanding as of December 31, 2019

 

 

1,084,125

 

 

$

1.07

 

Vested

 

 

(788,227

)

 

$

1.06

 

Forfeited

 

 

(39,087

)

 

$

0.23

 

Unvested restricted common stock outstanding as of December 31, 2020

 

 

256,811

 

 

$

1.22

 

Vested

 

 

(256,598

)

 

$

1.22

 

Forfeited

 

 

(213

)

 

$

1.35

 

Unvested restricted common stock outstanding as of December 31, 2021

 

 

 

 

$

 

Schedule of Stock Option Activity

The following table summarizes the stock option activity of the Company’s plans as of and for the years ended December 31, 2021 and 2020:

 

 

 

Number of
shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

(in years)

 

Options outstanding as of December 31, 2020

 

 

4,094,544

 

 

$

1.88

 

 

 

8.58

 

 

$

6,635,627

 

Granted

 

 

6,200,841

 

 

$

7.53

 

 

 

 

 

 

 

Exercised

 

 

(638,754

)

 

$

1.66

 

 

 

 

 

 

 

Cancelled

 

 

(283,638

)

 

$

3.34

 

 

 

 

 

 

 

Options outstanding as of December 31, 2021

 

 

9,372,993

 

 

$

5.59

 

 

 

8.55

 

 

$

51,415,394

 

Options exercisable as of December 31, 2021

 

 

2,117,654

 

 

$

2.56

 

 

 

6.52

 

 

$

17,759,485

 

Schedule of Weighted Average Assumptions Used to Estimate Grant Date Fair Value of Stock Options

The weighted average assumptions used to estimate the grant date fair value of the stock options using the Black-Scholes option pricing model were as follows:

 

 

 

2021

 

2020

Expected option life (in years)

 

6.2

 

5.0 – 6.1

Expected volatility

 

72%

 

67% – 72%

Risk-free interest rate

 

0.5%

 

0.4% – 1.4%

Expected dividend yield

 

— %

 

— %

Schedule of Stock-based Compensation Expense The Company recorded stock-based compensation expense in the following expense categories in its accompanying statements of operations:

 

 

 

Year Ended
December 31,

 

 

 

2021

 

 

2020

 

 

 

(in thousands)

 

Research and development

 

$

4,616

 

 

$

1,003

 

General and administrative

 

 

3,217

 

 

 

761

 

Total

 

$

7,833

 

 

$

1,764